FERITERO FCM INJ 500MG VIAL

About

FERITERO FCM INJ 500MG VIAL contains Ferric Carboxymaltose (FCM), an intravenous iron preparation used for the rapid and effective treatment of iron deficiency anemia (IDA). This medication is particularly indicated when oral iron supplements are ineffective, poorly tolerated, or when there is a clinical need for rapid iron repletion. FCM is a stable iron complex that allows for the administration of a high dose of iron in a single or few sessions, minimizing the need for frequent infusions. Once administered, the iron complex is taken up by cells of the reticuloendothelial system, where iron is slowly released to transferrin, the protein responsible for transporting iron to erythroid precursor cells in the bone marrow for hemoglobin synthesis.

The controlled release mechanism ensures efficient iron delivery to the sites of erythropoiesis, leading to a rapid increase in hemoglobin levels and improvement in symptoms associated with IDA, such as fatigue, weakness, and shortness of breath. FCM is a preferred option for patients with chronic kidney disease, inflammatory bowel disease, postpartum anemia, or those undergoing chemotherapy, where oral iron absorption may be impaired or contraindicated. Its efficacy and convenience make it a valuable therapeutic option for managing moderate to severe iron deficiency anemia.

Uses

• Iron deficiency anemia (IDA)
• IDA in chronic kidney disease (CKD) patients
• IDA in inflammatory bowel disease (IBD)
• Postpartum iron deficiency anemia

Directions For Use

Administered intravenously by a healthcare professional, typically as an infusion over a specified period.

Benefits

• Rapid and effective iron repletion
• Suitable for patients intolerant to oral iron
• Avoids gastrointestinal side effects of oral iron
• Convenient single or few dose regimen
• Quickly improves hemoglobin levels and symptoms
• Effective in various chronic conditions causing IDA

Side Effects

• Nausea
• Headache
• Dizziness
• Hypertension
• Injection site reactions
• Hypophosphatemia
• Flushing
• Rash
• Dysgeusia
• Abdominal pain
• Constipation
• Muscle pain

Safety Measures

• Alcohol - No specific interaction with alcohol; however, underlying conditions causing IDA may be affected by alcohol consumption.
• Pregnancy - Use only if clearly needed, especially in the second and third trimesters; consult a doctor to weigh risks and benefits.
• Breastfeeding - Use with caution; consult a healthcare provider as it is unknown if iron is excreted in human milk in significant amounts.
• Liver - Use with caution in patients with acute or chronic liver disease; monitor liver function during treatment.
• Kidney - Generally safe and effective for IDA in CKD patients; no dose adjustment is typically needed.
• Lung - No specific lung-related precautions; generally safe for patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.